Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing
Vogelaar, Ingrid P.; van der Post, Rachel S.; Van Krieken, J. Han J M; Spruijt, Liesbeth; van Zelst-Stams, Wendy A. G.; Kets, C. Marleen; Lubinski, Jan; Jakubowska, Anna; Teodorczyk, Urszula; Aalfs, Cora M.; Van Hest, Liselotte P.; Pinheiro, Hugo; Oliveira, Carla; Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R; De Ligt, Joep; Vissers, Lisenka E L M; Hoischen, Alexander; Gilissen, Christian; Van De Vorst, Maartje; Goeman, Jelle J.; Schackert, Hans K; Ranzani, Guglielmina N.; Molinaro, Valeria; García, Encarna B.Gómez; Hes, Frederik J.; Holinski-Feder, Elke; Genuardi, Maurizio; Ausems, Margreet G.E.M.; Sijmons, Rolf H.; Wagner, Anja; Van Der Kolk, Lizet E.; Bjørnevoll, Inga; Høberg Vetti, Hildegunn; van Kessel, Ad Geurts; Kuiper, Roland P.; Ligtenberg, Marjolijn J. L.; Hoogerbrugge, Nicoline
(2017) European Journal of Human Genetics, volume 25, issue 11, pp. 1246 - 1252
(Article)
Abstract
Recognition of individuals with a genetic predisposition to gastric cancer (GC) enables preventive measures. However, the underlying cause of genetic susceptibility to gastric cancer remains largely unexplained. We performed germline whole-exome sequencing on leukocyte DNA of 54 patients from 53 families with genetically unexplained diffuse-type and intestinal-type GC to identify
... read more
novel GC-predisposing candidate genes. As young age at diagnosis and familial clustering are hallmarks of genetic tumor susceptibility, we selected patients that were diagnosed below the age of 35, patients from families with two cases of GC at or below age 60 and patients from families with three GC cases at or below age 70. All included individuals were tested negative for germline CDH1 mutations before or during the study. Variants that were possibly deleterious according to in silico predictions were filtered using several independent approaches that were based on gene function and gene mutation burden in controls. Despite a rigorous search, no obvious candidate GC predisposition genes were identified. This negative result stresses the importance of future research studies in large, homogeneous cohorts.
show less
Download/Full Text
Keywords: Genetics, Genetics(clinical), Journal Article
ISSN: 1018-4813
Publisher: Springer Nature
Note: Funding Information: We thank Lilian Vreede, Hanna Feunekes, Eveline Kamping and Neeltje Arts from the Radboud university medical center for excellent technical assistance. This work was supported by the Radboud university medical center for Oncology, granted in 2010, the Dutch Cancer Society (KUN 2013-5876, RSvdP), ZONMW (917-10-358), the Deutsche Krebshilfe Grant 70-2371, FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, by Portuguese funds through the Portuguese Foundation for Science and Technology (FCT)/Ministério da Ciência, Tecnologia e Inovação, in the framework of the projects: (1) 'Institute for Research and Innovation in Health Sciences' (POCI-01-0145-FEDER-007274); (2) FCOMP-01-0124-FEDER-015779 (ref. FCT PTDC/SAU-GMG/110785/2009), a Post-doc grant to HP (ref. SFRH/BPD/79499/2011), by the US National Human Genome Research Institute (NHGRI) National Heart Lung and Blood Institute (NHBLI) grant U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics, NINDS grant RO1 NS058529 to JRL and NHGRI 5U54HG003273 to RAG. Publisher Copyright: © 2017 The Author(s).
(Peer reviewed)